These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 28694202

  • 1. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea.
    Lee S, Song KH, Jung SI, Park WB, Lee SH, Kim YS, Kwak YG, Kim YK, Kiem SM, Kim HI, Kim ES, Park KH, Kim NJ, Jang HC, Kim HB, Korea INfectious Diseases (KIND) study group.
    Clin Microbiol Infect; 2018 Feb; 24(2):152-158. PubMed ID: 28694202
    [Abstract] [Full Text] [Related]

  • 2. Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia.
    Monogue ML, Ortwine JK, Wei W, Eljaaly K, Bhavan KP.
    J Infect Public Health; 2018 Feb; 11(5):727-731. PubMed ID: 29526442
    [Abstract] [Full Text] [Related]

  • 3. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.
    Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Cosgrove SE, Sakoulas G, Perencevich EN.
    BMC Infect Dis; 2011 Oct 19; 11():279. PubMed ID: 22011388
    [Abstract] [Full Text] [Related]

  • 4. Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.
    Pollett S, Baxi SM, Rutherford GW, Doernberg SB, Bacchetti P, Chambers HF.
    Antimicrob Agents Chemother; 2016 Aug 19; 60(8):4684-9. PubMed ID: 27216053
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia.
    Twilla JD, Algrim A, Adams EH, Samarin M, Cummings C, Finch CK.
    Am J Med Sci; 2020 Jul 19; 360(1):35-41. PubMed ID: 32376001
    [Abstract] [Full Text] [Related]

  • 6. Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?
    Lee S, Choe PG, Song KH, Park SW, Kim HB, Kim NJ, Kim EC, Park WB, Oh MD.
    Antimicrob Agents Chemother; 2011 Nov 19; 55(11):5122-6. PubMed ID: 21825299
    [Abstract] [Full Text] [Related]

  • 7. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
    Lee S, Kwon KT, Kim HI, Chang HH, Lee JM, Choe PG, Park WB, Kim NJ, Oh MD, Song DY, Kim SW.
    Microb Drug Resist; 2014 Dec 19; 20(6):568-74. PubMed ID: 25000230
    [Abstract] [Full Text] [Related]

  • 8. Does the Beta-Lactam Matter? Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections.
    Burrelli CC, Broadbent EK, Margulis A, Snyder GM, Gold HS, McCoy C, Mahoney MV, Hirsch EB.
    Chemotherapy; 2018 Dec 19; 63(6):345-351. PubMed ID: 30965335
    [Abstract] [Full Text] [Related]

  • 9. A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections.
    Miller MA, Fish DN, Barber GR, Barron MA, Goolsby TA, Moine P, Mueller SW.
    J Microbiol Immunol Infect; 2020 Apr 19; 53(2):321-327. PubMed ID: 30190234
    [Abstract] [Full Text] [Related]

  • 10. Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review.
    Loubet P, Burdet C, Vindrios W, Grall N, Wolff M, Yazdanpanah Y, Andremont A, Duval X, Lescure FX.
    Clin Microbiol Infect; 2018 Feb 19; 24(2):125-132. PubMed ID: 28698037
    [Abstract] [Full Text] [Related]

  • 11. Methicillin-Susceptible Staphylococcus Aureus Bacteremia: Cefazolin in Prime But Nafcillin Not Ready for an Exit.
    Sarria JC.
    Am J Med Sci; 2020 Jul 19; 360(1):3-4. PubMed ID: 32439151
    [No Abstract] [Full Text] [Related]

  • 12. Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.
    McDanel JS, Roghmann MC, Perencevich EN, Ohl ME, Goto M, Livorsi DJ, Jones M, Albertson JP, Nair R, O'Shea AMJ, Schweizer ML.
    Clin Infect Dis; 2017 Jul 01; 65(1):100-106. PubMed ID: 28379314
    [Abstract] [Full Text] [Related]

  • 13. Retrospective Analysis of Adverse Drug Events Between Nafcillin Versus Cefazolin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections.
    Chan L, Chan-Tompkins NH, Como J, Guarascio AJ.
    Ann Pharmacother; 2020 Jul 01; 54(7):662-668. PubMed ID: 31888347
    [Abstract] [Full Text] [Related]

  • 14. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
    Davis JS, Turnidge J, Tong S.
    Int J Antimicrob Agents; 2018 Aug 01; 52(2):297-300. PubMed ID: 29499317
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort.
    Song KH, Jung SI, Lee S, Park S, Kiem SM, Lee SH, Kwak YG, Kim YK, Jang HC, Kim YS, Kim HI, Kim CJ, Park KH, Kim NJ, Oh MD, Kim HB, Korea INfectious Diseases (KIND) study group.
    Eur J Clin Microbiol Infect Dis; 2017 Feb 01; 36(2):285-294. PubMed ID: 27714592
    [Abstract] [Full Text] [Related]

  • 16. Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study.
    Bai AD, Showler A, Burry L, Steinberg M, Ricciuto DR, Fernandes T, Chiu A, Raybardhan S, Science M, Fernando E, Tomlinson G, Bell CM, Morris AM.
    J Antimicrob Chemother; 2015 May 01; 70(5):1539-46. PubMed ID: 25614044
    [Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting.
    Youngster I, Shenoy ES, Hooper DC, Nelson SB.
    Clin Infect Dis; 2014 Aug 01; 59(3):369-75. PubMed ID: 24785233
    [Abstract] [Full Text] [Related]

  • 18. Meta-analysis of trials comparing cefazolin to antistaphylococcal penicillins in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia.
    Rindone JP, Mellen CK.
    Br J Clin Pharmacol; 2018 Jun 01; 84(6):1258-1266. PubMed ID: 29600576
    [Abstract] [Full Text] [Related]

  • 19. Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.
    Agnello S, Wardlow LC, Reed E, Smith JM, Coe K, Day SR.
    Int J Antimicrob Agents; 2021 Aug 01; 58(2):106363. PubMed ID: 34033912
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study.
    Oh DH, Kim JJ, Kim J, Seong H, Lee SJ, Kim YC, Kim EJ, Jung IY, Jeong WY, Jeong SJ, Ku NS, Han SH, Choi JY, Song YG, Kim JM.
    BMC Infect Dis; 2018 Jan 30; 18(1):60. PubMed ID: 29378565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.